Table 4. Correlation of E2Fs’ genes expression with OS in GC patients with gender expression status.

E2Fs	Gender	Cases	HR (95% CI)	P-value
E2F1	Male	545	2.33 (1.84−2.95)	5.1e−13*
	Female	876	2 (1.69−2.38)	7.8e−16*
E2F2	Male	349	0.53 (0.39−0.72)	2.6e−05*
	Female	187	0.53 (0.31−0.91)	0.02*
E2F3	Male	545	2.08 (1.68−2.58)	9e−12*
	Female	236	1.54 (1.05−2.25)	0.026
E2F4	Male	545	2.24 (1.79−2.81)	7.2e−13*
	Female	236	2.17 (1.53−3.09)	8.6e−06*
E2F5	Male	545	0.65 (0.52−0.81)	9e−05*
	Female	236	0.59 (0.42−0.84)	0.003*
E2F6	Male	545	0.89 (0.71−1.11)	0.28
	Female	236	0.56 (0.39−0.79)	0.00097*
E2F7	Male	349	0.6 (0.45−0.82)	0.0011*
	Female	187	0.48 (0.3−0.75)	0.0011*

^*P<0.05.